Skip to main content

Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes

  • Protocol
Book cover Molecular Toxicology Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 291))

  • 960 Accesses

Abstract

Specific recurring chromosomal translocations and deletions are found in a variety of cancers. In hematopoietic malignancies, many of these chromosomal aberrations result from mistakes involving V(D)J recombination. V(D)J recombination is required for the formation of functional T-cell receptor genes in T cells and antibody genes in B cells. This is an inherently dangerous process, however, because double-strand breaks are introduced into the chromosomes. Molecular evidence indicates that failure of the fidelity of this process results in the activation of proto-oncogenes or the inactivation of tumor suppressor genes. Here we describe sensitive, quantitative PCR assays for the measurement of such events in human lymphocytes. One assay measures the frequency of t(14;18) translocations that result in the dysfunctional regulation of the antiapoptotic gene BCL-2. The other assay measures the frequency of a deletion caused by illegitimate V(D)J recombination in the X-linked HPRT gene.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lipford, E., Wright, J. J., Urba, W., et al. (1987) Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region. Blood 70, 1816–1823.

    PubMed  CAS  Google Scholar 

  2. Yunis, J. J., Oken, M. M., Kaplan, M. E., Ensrud, K. E., Howe, R. R., and Theologides, A. (1982) Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin’s lymphomas. N. Engl. J. Med. 307, 1231–1236.

    Article  PubMed  CAS  Google Scholar 

  3. Hockenbery, D., Nunez, G., Milliman, C, Schreiber, R. D., and Korsmeyer, S. J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334–336.

    Article  PubMed  CAS  Google Scholar 

  4. Crescenzi, M., Seto, M., Herzig, G. P., Weiss, P. D., Griffith, R. C, and Korsmeyer, S. J. (1988) Thermostable DNA polymerase chain reaction amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc. Natl. Acad. Sci. USA 85, 4869–4873.

    Article  PubMed  CAS  Google Scholar 

  5. Ngan, B. Y., Nourse, J., and Cleary, M. L. (1989) Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 73, 1759–1762.

    PubMed  CAS  Google Scholar 

  6. Cotter, F., Price, C, Zucca, E., and Young, B. D. (1990) Direct sequence analysis of the 14q+ and 18q-chromosome junctions in follicular lymphoma. Blood 76, 131–135.

    PubMed  CAS  Google Scholar 

  7. Eick, S., Krieger, G., Bolz, I., and Kneba, M. (1990) Sequence analysis of amplified t(14;18) chromosomal breakpoints in B-cell lymphomas. J. Pathol. 162, 127–133.

    Article  PubMed  CAS  Google Scholar 

  8. Liu, Y., Hernandez, A. M., Shibata, D., and Cortopassi, G. A. (1994) BCL2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. USA 91, 8910–8914.

    Article  PubMed  CAS  Google Scholar 

  9. Zhang, X. Y. and Ehrlich, M. (1994) Detection and quantitation of low numbers of chromosomes containing bcl-2 oncogene translocations using semi-nested PCR. Biotechniques 16, 502–507.

    PubMed  CAS  Google Scholar 

  10. Fuscoe, J. C, Setzer, R. W., Collard, D. D., and Moore, M. M. (1996) Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens. Carcinogenesis 17, 1013–1020.

    Article  PubMed  CAS  Google Scholar 

  11. Fuscoe, J. C, Zimmerman, L. J., Lippert, M. J., Nicklas, J. A., O’Neill, J. P., and Albertini, R. J. (1991) V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res. 51, 6001–6005.

    PubMed  CAS  Google Scholar 

  12. Fuscoe, J. C, Zimmerman, L. J., Harrington-Brock, K, et al. (1992) V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans. Mutat. Res. 283, 13–20.

    Article  PubMed  CAS  Google Scholar 

  13. Fuscoe, J. C, Vira, L. K., Collard, D. D., and Moore, M. M. (1997) Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans. Environ. Mol. Mutagen. 29, 28–35.

    Article  PubMed  CAS  Google Scholar 

  14. Chen, C. L., Fuscoe, J. C, Liu, Q., and Relling, M. V. (1996) Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells. Blood 88, 2210–2218.

    PubMed  CAS  Google Scholar 

  15. Chen, C. L., Fuscoe, J. C, Liu, Q., Pui, C. H., Mahmoud, H. H., and Relling, M. V. (1996) Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide. J. Natl. Cancer Inst. 88, 1840–1847.

    Article  PubMed  CAS  Google Scholar 

  16. Chen, C. L., Woo, M. H., Neale, G. A., et al. (1998) A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt. Mutat. Res. 403, 113–125.

    PubMed  CAS  Google Scholar 

  17. Fuscoe, J. C, Knapp, G. W., Hanley, N. M., et al. (1998) The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy. Mutat. Res. 419, 107–121.

    PubMed  CAS  Google Scholar 

  18. Scheerer, J. B., Xi, L., Knapp, G. W., Setzer, R. W., Bigbee, W. L., and Fuscoe, J. C. (1999) Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults. Mutat. Res. 431, 291–303.

    PubMed  CAS  Google Scholar 

  19. Edwards, A., Voss, H., Rice, P., et al. (1990) Automated DNA sequencing of the human HPRT locus. Genomics 6, 593–608.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc.

About this protocol

Cite this protocol

Fuscoe, J.C. (2005). Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes. In: Keohavong, P., Grant, S.G. (eds) Molecular Toxicology Protocols. Methods in Molecular Biology™, vol 291. Humana Press. https://doi.org/10.1385/1-59259-840-4:171

Download citation

  • DOI: https://doi.org/10.1385/1-59259-840-4:171

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-084-7

  • Online ISBN: 978-1-59259-840-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics